HAEGARDA
Google image searchProduct monograph
Active ingredient
c1 esterase inhibitor (human), 3000 UNIT/VIAL
DIN: 02468077
Dosage form(s): KIT, POWDER FOR SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: FOR SUBCUTANEOUS ADMINISTRATION ONLY - SINGLE USE VIAL & DILUENT
Schedule: Schedule D
Company: CSL BEHRING CANADA INC
Date: 23-JAN-2020
ATC:
- B06 — OTHER HEMATOLOGICAL AGENTS (ATC, ATC/DDD, )
- B06A — OTHER HEMATOLOGICAL AGENTS (ATC, ATC/DDD)
- B06AC — Drugs used in hereditary angioedema (ATC, ATC/DDD)
- B06AC01 — C1-INHIBITOR, PLASMA DERIVED (ATC/DDD)
Reference brand drug: Berinert, Cinryze, Haegarda
Pharmaceutical standard: MFR
